BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 32183400)

  • 1. Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis.
    Lapitz A; Arbelaiz A; O'Rourke CJ; Lavin JL; Casta A; Ibarra C; Jimeno JP; Santos-Laso A; Izquierdo-Sanchez L; Krawczyk M; Perugorria MJ; Jimenez-Aguero R; Sanchez-Campos A; Riaño I; Gónzalez E; Lammert F; Marzioni M; Macias RIR; Marin JJG; Karlsen TH; Bujanda L; Falcón-Pérez JM; Andersen JB; Aransay AM; Rodrigues PM; Banales JM
    Cells; 2020 Mar; 9(3):. PubMed ID: 32183400
    [No Abstract]   [Full Text] [Related]  

  • 2. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
    Lapitz A; Azkargorta M; Milkiewicz P; Olaizola P; Zhuravleva E; Grimsrud MM; Schramm C; Arbelaiz A; O'Rourke CJ; La Casta A; Milkiewicz M; Pastor T; Vesterhus M; Jimenez-Agüero R; Dill MT; Lamarca A; Valle JW; Macias RIR; Izquierdo-Sanchez L; Pérez Castaño Y; Caballero-Camino FJ; Riaño I; Krawczyk M; Ibarra C; Bustamante J; Nova-Camacho LM; Falcon-Perez JM; Elortza F; Perugorria MJ; Andersen JB; Bujanda L; Karlsen TH; Folseraas T; Rodrigues PM; Banales JM
    J Hepatol; 2023 Jul; 79(1):93-108. PubMed ID: 36868481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.
    Arbelaiz A; Azkargorta M; Krawczyk M; Santos-Laso A; Lapitz A; Perugorria MJ; Erice O; Gonzalez E; Jimenez-Agüero R; Lacasta A; Ibarra C; Sanchez-Campos A; Jimeno JP; Lammert F; Milkiewicz P; Marzioni M; Macias RIR; Marin JJG; Patel T; Gores GJ; Martinez I; Elortza F; Falcon-Perez JM; Bujanda L; Banales JM
    Hepatology; 2017 Oct; 66(4):1125-1143. PubMed ID: 28555885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis.
    Li L; Masica D; Ishida M; Tomuleasa C; Umegaki S; Kalloo AN; Georgiades C; Singh VK; Khashab M; Amateau S; Li Z; Okolo P; Lennon AM; Saxena P; Geschwind JF; Schlachter T; Hong K; Pawlik TM; Canto M; Law J; Sharaiha R; Weiss CR; Thuluvath P; Goggins M; Shin EJ; Peng H; Kumbhari V; Hutfless S; Zhou L; Mezey E; Meltzer SJ; Karchin R; Selaru FM
    Hepatology; 2014 Sep; 60(3):896-907. PubMed ID: 24497320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein and miRNA profile of circulating extracellular vesicles in patients with primary sclerosing cholangitis.
    Povero D; Tameda M; Eguchi A; Ren W; Kim J; Myers R; Goodman ZD; Harrison SA; Sanyal AJ; Bosch J; Ohno-Machado L; Feldstein AE
    Sci Rep; 2022 Feb; 12(1):3027. PubMed ID: 35194091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylcholine in bile-derived small extracellular vesicles as a novel biomarker of cholangiocarcinoma.
    Muraki R; Morita Y; Ida S; Kitajima R; Furuhashi S; Takeda M; Kikuchi H; Hiramatsu Y; Takanashi Y; Hamaya Y; Sugimoto K; Ito J; Kawata K; Kawasaki H; Sato T; Kahyo T; Setou M; Takeuchi H
    Cancer Med; 2023 Jun; 12(12):13007-13018. PubMed ID: 37096775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
    Banales JM; Iñarrairaegui M; Arbelaiz A; Milkiewicz P; Muntané J; Muñoz-Bellvis L; La Casta A; Gonzalez LM; Arretxe E; Alonso C; Martínez-Arranz I; Lapitz A; Santos-Laso A; Avila MA; Martínez-Chantar ML; Bujanda L; Marin JJG; Sangro B; Macias RIR
    Hepatology; 2019 Aug; 70(2):547-562. PubMed ID: 30325540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Claudin-3 in extracellular vesicles from human bile as biomarkers of cholangiocarcinoma.
    Ikeda C; Haga H; Makino N; Inuzuka T; Kurimoto A; Ueda T; Matsuda A; Kakizaki Y; Ishizawa T; Kobayashi T; Sugahara S; Tsunoda M; Suda K; Ueno Y
    Sci Rep; 2021 Jan; 11(1):1195. PubMed ID: 33441949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma.
    Voigtländer T; Metzger J; Husi H; Kirstein MM; Pejchinovski M; Latosinska A; Frantzi M; Mullen W; Book T; Mischak H; Manns MP
    J Biomed Sci; 2020 Jan; 27(1):13. PubMed ID: 31900160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.
    Zeuschner P; Linxweiler J; Junker K
    Expert Rev Mol Diagn; 2020 Feb; 20(2):151-167. PubMed ID: 31499007
    [No Abstract]   [Full Text] [Related]  

  • 11. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis - The promise of DNA methylation and molecular biomarkers.
    Vedeld HM; Folseraas T; Lind GE
    JHEP Rep; 2020 Oct; 2(5):100143. PubMed ID: 32939446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Internal Radiotherapy Changes the Immune Profiles of Extracellular Vesicles and Their Immune Origin in Patients with Inoperable Cholangiocarcinoma.
    Haag F; Manikkam A; Kraft D; Bär C; Wilke V; Nowak AJ; Bertrand J; Omari J; Pech M; Gylstorff S; Relja B
    Cells; 2022 Jul; 11(15):. PubMed ID: 35954154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs and extracellular vesicles in cholangiopathies.
    Olaizola P; Lee-Law PY; Arbelaiz A; Lapitz A; Perugorria MJ; Bujanda L; Banales JM
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1293-1307. PubMed ID: 28711597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
    Song J; Li Y; Bowlus CL; Yang G; Leung PSC; Gershwin ME
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):134-149. PubMed ID: 31463807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of urinary extracellular vesicle isolation methods for transcriptomic biomarker research in diabetic kidney disease.
    Barreiro K; Dwivedi OP; Leparc G; Rolser M; Delic D; Forsblom C; Groop PH; Groop L; Huber TB; Puhka M; Holthofer H
    J Extracell Vesicles; 2020 Dec; 10(2):e12038. PubMed ID: 33437407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A total transcriptome profiling method for plasma-derived extracellular vesicles: applications for liquid biopsies.
    Amorim MG; Valieris R; Drummond RD; Pizzi MP; Freitas VM; Sinigaglia-Coimbra R; Calin GA; Pasqualini R; Arap W; Silva IT; Dias-Neto E; Nunes DN
    Sci Rep; 2017 Oct; 7(1):14395. PubMed ID: 29089558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: diagnosis and surveillance.
    Ehlken H; Zenouzi R; Schramm C
    Curr Opin Gastroenterol; 2017 Mar; 33(2):78-84. PubMed ID: 28146445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of prostate cancer-specific transcripts in extracellular vesicles isolated from post-DRE urine.
    Pellegrini KL; Patil D; Douglas KJS; Lee G; Wehrmeyer K; Torlak M; Clark J; Cooper CS; Moreno CS; Sanda MG
    Prostate; 2017 Jun; 77(9):990-999. PubMed ID: 28419548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles and Their Role in Urologic Malignancies.
    Junker K; Heinzelmann J; Beckham C; Ochiya T; Jenster G
    Eur Urol; 2016 Aug; 70(2):323-31. PubMed ID: 26924769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.